ImmunologybioRxivPreprint
Immunogenicity and efficacy of a subcutaneously administered, adjuvanted vaccine containing modified S1 spike protein of SARS-CoV-2 variant C.1.2
Michael Bowe, Emily Wright, Peter Pushko…·David Craig Wright
This paper evaluates a subcutaneously administered vaccine targeting the S1 spike protein of SARS-CoV-2 variant C.1.2, showing robust IgG responses and protection against Omicron BA.1 challenge in hamsters.
DOI 10.1101/2023.08.31.555805